Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix total assets
Total assets on the balance sheet at the end of each period.
Renalytix's total assets was $4.79M at Sep 30, 2024. For fiscal 2024 it was $7.97M, down 74.0% from the year before. The highest annual figure on record is $78.58M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $7.97M | -74.0% |
| FY2023 | Jun 30, 2023 | $30.63M | -38.8% |
| FY2022 | Jun 30, 2022 | $50.07M | -36.3% |
| FY2021 | Jun 30, 2021 | $78.58M | +276.3% |
| FY2020 | Jun 30, 2020 | $20.88M | +115.3% |
| FY2019 | Jun 30, 2019 | $9.70M | +8334.8% |
| FY2018 | Jun 30, 2018 | $115.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $4.79M | -75.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $7.97M | -74.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $8.77M | -78.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $11.28M | -63.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $19.54M | -49.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $30.63M | -38.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $39.80M | -10.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $30.66M | -43.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $38.71M | -50.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $50.07M | +139.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $44.47M | +358.4% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $54.36M | +47167.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $78.58M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $20.88M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $9.70M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $115.00K | – |
See a number that looks wrong?